Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function.
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
C D
CD
Griffiths
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
E S M
ES
Ng
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
S B
SB
Kangarloo
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
T S
TS
Williamson
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
M A
MA
Chaudhry
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
R
R
Booker
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
P
P
Duggan
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
P
P
Yue
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
L
L
Savoie
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
C
C
Brown
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
N
N
Cox-Kennett
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
J A
JA
Russell
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
A
A
Daly
Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
J
J
Storek
D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D015999:Multivariate Analysis; D019172:Transplantation Conditioning / Q000379:methods*; D016896:Treatment Outcome; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
D014740:Vidarabine; C024352:fludarabine